These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22696197)

  • 41. The cigarette controversy.
    Cummings KM; Brown A; O'Connor R
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1070-6. PubMed ID: 17548665
    [TBL] [Abstract][Full Text] [Related]  

  • 42. "All Weather Friends": How China Transformed Zimbabwe's Tobacco Sector.
    Fang J; De Souza L; Smith J; Lee K
    Int J Environ Res Public Health; 2020 Jan; 17(3):. PubMed ID: 31979132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Tobacco industry strategies to attract young smokers in Spain: a review of companies' internal documents].
    Soto Mas F; Jacobson HE; Fernández E
    Adicciones; 2011; 23(4):327-34. PubMed ID: 22249897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Signed, sealed and delivered: "big tobacco" in Hollywood, 1927-1951.
    Lum KL; Polansky JR; Jackler RK; Glantz SA
    Tob Control; 2008 Oct; 17(5):313-23. PubMed ID: 18818225
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Learning from Philip Morris: Japan Tobacco's strategies regarding evidence of tobacco health harms as revealed in internal documents from the American tobacco industry.
    Iida K; Proctor RN
    Lancet; 2004 May; 363(9423):1820-4. PubMed ID: 15172783
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Building alliances in unlikely places: progressive allies and the Tobacco Institute's coalition strategy on cigarette excise taxes.
    Campbell RB; Balbach ED
    Am J Public Health; 2009 Jul; 99(7):1188-96. PubMed ID: 19443832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent tobacco tax rate adjustment and its potential impact on tobacco control in China.
    Hu TW; Mao Z; Shi J
    Tob Control; 2010 Feb; 19(1):80-2. PubMed ID: 19850552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Old ways, new means: tobacco industry funding of academic and private sector scientists since the Master Settlement Agreement.
    Schick SF; Glantz SA
    Tob Control; 2007 Jun; 16(3):157-64. PubMed ID: 17565125
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Waiting for the opportune moment: the tobacco industry and marijuana legalization.
    Barry RA; Hiilamo H; Glantz SA
    Milbank Q; 2014 Jun; 92(2):207-42. PubMed ID: 24890245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Response of the tobacco industry to the creation of smoke-free environments in Brazil].
    Bialous SA; Presman S; Gigliotti A; Muggli M; Hurt R
    Rev Panam Salud Publica; 2010 Apr; 27(4):283-90. PubMed ID: 20512231
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are marketing campaigns in Taiwan by foreign tobacco companies targeting young smokers?
    Wen CP; Chen T; Tsai YY; Tsai SP; Chung WS; Cheng TY; Levy DT; Hsu CC; Peterson R; Liu WY
    Tob Control; 2005 Jun; 14 Suppl 1(Suppl 1):i38-44. PubMed ID: 15923447
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The tobacco endgame in Hong Kong: public support for a total ban on tobacco sales.
    Wang MP; Wang X; Lam TH; Viswanath K; Chan SS
    Tob Control; 2015 Mar; 24(2):162-7. PubMed ID: 24046209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. "If we can just 'stall' new unfriendly legislations, the scoreboard is already in our favour": transnational tobacco companies and ingredients disclosure in Thailand.
    MacKenzie R; Collin J; Sriwongcharoen K; Muggli ME
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii79-87. PubMed ID: 15564225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tobacco product regulation--a public health approach.
    Deyton L; Sharfstein J; Hamburg M
    N Engl J Med; 2010 May; 362(19):1753-6. PubMed ID: 20410498
    [No Abstract]   [Full Text] [Related]  

  • 55. Prospects for tobacco control in Zimbabwe: a historical perspective.
    Woelk G; Mtisi S; Vaughan JP
    Health Policy; 2001 Sep; 57(3):179-92. PubMed ID: 11459625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. KT&G: From Korean monopoly to 'a global name in the tobacco industry'.
    Lee K; Gong L; Eckhardt J; Holden C; Lee S
    Glob Public Health; 2017 Mar; 12(3):300-314. PubMed ID: 28139963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tobacco industry consumer research on smokeless tobacco users and product development.
    Mejia AB; Ling PM
    Am J Public Health; 2010 Jan; 100(1):78-87. PubMed ID: 19910355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pushing up smoking incidence: plans for a privatised tobacco industry in Moldova.
    Gilmore AB; Radu-Loghin C; Zatushevski I; McKee M
    Lancet; 2005 Apr 9-15; 365(9467):1354-9. PubMed ID: 15823388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Lebanese Regie state-owned tobacco monopoly: lessons to inform monopoly-focused endgame strategies.
    Alaouie H; Branston JR; Bloomfield MJ
    BMC Public Health; 2022 Aug; 22(1):1632. PubMed ID: 36038852
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Taiwan Tobacco and Liquor Corporation: To 'join the ranks of global companies'.
    Eckhardt J; Fang J; Lee K
    Glob Public Health; 2017 Mar; 12(3):335-350. PubMed ID: 28139964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.